-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2023 to Q2 2025.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2025 was -$195K.
- Silexion Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5.1M, a 878% increase from 2023.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)